Published: 12/21/2020 12:17 GMT (IPIX) - FDA Grants Ind Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals’ Brilacidin for Treating Covid-19.
Innovation Pharmaceuticals - Phase 2 Clinical Trial Expected to Enroll About 120 Patients With Moderate-to-severe Covid-19.
